Last updated on June 2019

A Study to Investigate the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) as an Adjunctive Therapy in Children and Adults With Lennox-Gastaut Syndrome


Brief description of study

This is a two-part, multicenter, double-blind, parallel-group, placebo controlled study to evaluate the effect of ZX008 when used as adjunctive therapy for the treatment of uncontrolled seizures in children and adults with Lennox-Gastaut syndrome (LGS).

Clinical Study Identifier: NCT03355209

Find a site near you

Start Over

Center for Neurosciences

Tucson, AZ United States
  Connect »

Florida Hospital Orlando

Orlando, FL United States
  Connect »

Pediatric Neurology, PA

Orlando, FL United States
  Connect »

Spectrum Health

Grand Rapids, MI United States
  Connect »

William Beaumont Hospital

Royal Oak, MI United States
  Connect »

Mayo Clinic

Rochester, MN United States
  Connect »

Minnesota Epilepsy Group, PA

Saint Paul, MN United States
  Connect »

University Hospital Cleveland

Cleveland, OH United States
  Connect »

Wellspan Pediatric Neurology

Manchester, PA United States
  Connect »

Baylor College of Medicine

San Antonio, TX United States
  Connect »

University of Utah

Salt Lake City, UT United States
  Connect »

Seattle Children's Hospital

Seattle, WA United States
  Connect »

Sick Kids

Toronto, ON Canada
  Connect »

NZOZ Vitamed

Bydgoszcz, Poland
  Connect »